Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+1.92%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$79.7B
AUM Growth
-$2.55B
(-3.1%)
Cap. Flow
-$8.7B
Cap. Flow
% of AUM
-10.91%
Top 10 Holdings %
Top 10 Hldgs %
26.07%
Holding
2,504
New
414
Increased
840
Reduced
685
Closed
192
Top Buys
| 1 |
Exxon Mobil
XOM
|
$882M |
| 2 |
Apple
AAPL
|
$350M |
| 3 |
Marvell Technology
MRVL
|
$304M |
| 4 |
UnitedHealth
UNH
|
$239M |
| 5 |
Old Dominion Freight Line
ODFL
|
$218M |
Top Sells
| 1 |
Chevron
CVX
|
$797M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$481M |
| 3 |
Labcorp
LH
|
$296M |
| 4 |
Pinnacle West Capital
PNW
|
$290M |
| 5 |
Walt Disney
DIS
|
$288M |
Sector Composition
| 1 | Technology | 26.48% |
| 2 | Financials | 13.94% |
| 3 | Healthcare | 12.34% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Tactile Systems Technology
TCMD
$300M
| $34K | ﹤0.01% |
2,892
-738
| -20% | -$8.68K |
|
1802
Quaker Houghton
KWR
$2.51B
| $33K | ﹤0.01% |
200
+7
| +4% | +$1.16K |
|
1803
Biohaven
BHVN
$1.68B
| $32K | ﹤0.01% |
939
+667
| +245% | +$22.7K |
|
1804
Burford Capital
BUR
$2.92B
| $32K | ﹤0.01% |
2,462
| – | – |
|
|
ALEX
1805
Alexander & Baldwin
ALEX
$1.41B
| $31K | ﹤0.01% |
1,853
| – | – |
|
1806
Endava
DAVA
$553M
| $31K | ﹤0.01% |
1,088
-170,082
| -99% | -$4.85M |
|
1807
Freedom Holding
FRHC
$10.4B
| $31K | ﹤0.01% |
412
| – | – |
|
1808
ScottsMiracle-Gro
SMG
$3.64B
| $31K | ﹤0.01% |
+481
| New | +$31K |
|
1809
South Plains Financial
SPFI
$658M
| $30K | ﹤0.01% |
+1,128
| New | +$30K |
|
1810
UFP Technologies
UFPT
$1.6B
| $30K | ﹤0.01% |
115
-1,471
| -93% | -$384K |
|
1811
Ferguson
FERG
$47.8B
| $29K | ﹤0.01% |
150
-5,240
| -97% | -$1.01M |
|
1812
Legacy Housing
LEGH
$670M
| $29K | ﹤0.01% |
+1,295
| New | +$29K |
|
1813
Gencor Industries
GENC
$237M
| $28K | ﹤0.01% |
1,448
+1,385
| +2,198% | +$26.8K |
|
1814
Mativ Holdings
MATV
$680M
| $28K | ﹤0.01% |
+1,662
| New | +$28K |
|
|
XIFR
1815
XPLR Infrastructure, LP
XIFR
$976M
| $28K | ﹤0.01% |
+1,039
| New | +$28K |
|
1816
H.B. Fuller
FUL
$3.37B
| $27K | ﹤0.01% |
352
+280
| +389% | +$21.5K |
|
1817
Ryerson Holding
RYI
$757M
| $27K | ﹤0.01% |
+1,424
| New | +$27K |
|
1818
Stepan Co
SCL
$1.13B
| $27K | ﹤0.01% |
+328
| New | +$27K |
|
1819
CGI
GIB
$21.6B
| $26K | ﹤0.01% |
264
+78
| +42% | +$7.68K |
|
1820
IDEX
IEX
$12.4B
| $26K | ﹤0.01% |
+132
| New | +$26K |
|
1821
Esperion Therapeutics
ESPR
$540M
| $25K | ﹤0.01% |
+11,694
| New | +$25K |
|
1822
Neuropace
NPCE
$322M
| $25K | ﹤0.01% |
3,426
-115
| -3% | -$839 |
|
1823
OneMain Financial
OMF
$7.31B
| $25K | ﹤0.01% |
+520
| New | +$25K |
|
1824
Vanda Pharmaceuticals
VNDA
$272M
| $25K | ﹤0.01% |
4,596
+3,266
| +246% | +$17.8K |
|
1825
InMode
INMD
$947M
| $24K | ﹤0.01% |
1,363
+2
| +0.1% | +$35 |
|